JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hallman, S. E.
Right arrow Articles by Uber, W. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hallman, S. E.
Right arrow Articles by Uber, W. E.
Related Collections
Right arrow Cardiovascular
Right arrow Complications
Right arrow Pharmacology

Anesth Analg 2005;100:946-948
© 2005 International Anesthesia Research Society
doi: 10.1213/01.ANE.0000146940.47989.5F

CARDIOVASCULAR ANESTHESIA

The Use of Argatroban for Carotid Endarterectomy in Heparin-Induced Thrombocytopenia

Sarah E. Hallman, MD*, Latha Hebbar, MD, FRCA*, Jay Robison, MD{dagger}, and Walter E. Uber, PharmD{ddagger}

*Department of Anesthesia and Perioperative Medicine, {dagger}Division of Vascular Surgery, {ddagger}Department of Pharmacy Services, Childrens Hospital, Medical University of South Carolina, Charleston

Address correspondence and reprint requests to Sarah E. Hallman, MD, Department of Anesthesia and Perioperative Medicine, Childrens Hospital, Medical University of South Carolina, 165 Ashley Ave., Suite 525, P.O. Box 250912, Charleston, SC 29425. Address e-mail to hallman{at}musc.edu.

Heparin-induced thrombocytopenia (HIT) is a major obstacle in cardiovascular surgeries. In this case report, we used argatroban, a direct thrombin inhibitor, to achieve and maintain anticoagulation for carotid endarterectomy. Unlike heparin, the direct thrombin inhibitors bind directly to thrombin, bypassing antithrombin III and the potential to precipitate HIT. A bolus of argatroban 150 µg/kg followed by an infusion of 5 µg · kg–1 · min–1 was used, and adequate anticoagulation was demonstrated with multiple laboratory tests (at 28 min, prothrombin time = 29.8 s, partial thromboplastin time = 69.1 s, international normalized ratio = 3.52 s, and activated clotting time = 220 s). The surgery was successful, and the patient was discharged the next day with no postoperative neurologic sequelae or other complications. We conclude that argatroban can be used safely and successfully for carotid endarterectomy in a patient with a history of HIT.




This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
J. H. Marymont, G. S. Murphy, and H. C. Gilbert
Intraoperative heparin and heparin-induced thrombocytopenia.
Anesth. Analg., January 1, 2006; 102(1): 328 - 328.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
P. Kopterides
What Is the Appropriate Anticoagulation Therapy in Patients with a History of Heparin-Induced Thrombocytopenia?
Anesth. Analg., December 1, 2005; 101(6): 1885 - 1885.
[Full Text] [PDF]


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2005 by the International Anesthesia Research Society.